{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T02:02:02Z","timestamp":1791597722999,"version":"4.3.4"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2009,11,2]],"date-time":"2009-11-02T00:00:00Z","timestamp":1257120000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2009,11,2]],"date-time":"2009-11-02T00:00:00Z","timestamp":1257120000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2010,1,28]]},"DOI":"10.1038\/onc.2009.359","type":"journal-article","created":{"date-parts":[[2009,11,2]],"date-time":"2009-11-02T11:13:37Z","timestamp":1257160417000},"page":"503-515","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":66,"title":["Chromosomal rearrangements after ex vivo Epstein\u2013Barr virus (EBV) infection of human B cells"],"prefix":"10.1038","volume":"29","author":[{"given":"S","family":"Lacoste","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Wiechec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A G","family":"dos Santos Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Guffei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Lowbeer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Benedek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Henriksson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Klein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Mai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,11,2]]},"reference":[{"key":"BFonc2009359_CR1","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1152\/physrev.00026.2007","volume":"88","author":"G Aubert","year":"2008","unstructured":"Aubert G, Lansdorp PM . (2008). Telomeres and aging. Physiol Rev 88: 557\u2013579.","journal-title":"Physiol Rev"},{"key":"BFonc2009359_CR2","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.canlet.2007.03.010","volume":"254","author":"MC Belfiore","year":"2007","unstructured":"Belfiore MC, Natoni A, Barzellotti R, Merendino N, Pessina G, Ghibelli L et al. (2007). Involvement of 5-lipoxygenase in survival of Epstein\u2013Barr virus (EBV)-converted B lymphoma cells. Cancer Lett 254: 236\u2013243.","journal-title":"Cancer Lett"},{"key":"BFonc2009359_CR3","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1038\/sj.onc.1209928","volume":"26","author":"A Caporali","year":"2007","unstructured":"Caporali A, Wark L, Vermolen BJ, Garini Y, Mai S . (2007). Telomeric aggregates and end-to-end chromosomal fusions require myc box II. Oncogene 26: 1398\u20131406.","journal-title":"Oncogene"},{"key":"BFonc2009359_CR4","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1073\/pnas.0408381102","volume":"102","author":"F Cerimele","year":"2005","unstructured":"Cerimele F, Battle T, Lynch R, Frank DA, Murad E, Cohen C et al. (2005). Reactive oxygen signaling and MAPK activation distinguish Epstein\u2013Barr Virus (EBV)-positive versus EBV-negative Burkitt's lymphoma. Proc Natl Acad Sci USA 102: 175\u2013179.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc2009359_CR5","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/1741-7007-2-12","volume":"2","author":"TC Chuang","year":"2004","unstructured":"Chuang TC, Moshir S, Garini Y, Chuang AY, Young IT, Vermolen B et al. (2004). The three-dimensional organization of telomeres in the nucleus of mammalian cells. BMC Biol 2: 12.","journal-title":"BMC Biol"},{"key":"BFonc2009359_CR6","first-page":"627","volume":"53","author":"N Ciobanu","year":"1986","unstructured":"Ciobanu N, Wiernik PH . (1986). Malignant lymphomas, AIDS, and the pathogenic role of Epstein\u2013Barr virus. Mt Sinai J Med 53: 627\u2013638.","journal-title":"Mt Sinai J Med"},{"key":"BFonc2009359_CR7","doi-asserted-by":"crossref","first-page":"3410","DOI":"10.1128\/jvi.68.5.3410-3414.1994","volume":"68","author":"CM Counter","year":"1994","unstructured":"Counter CM, Botelho FM, Wang P, Harley CB, Bacchetti S . (1994). Stabilization of short telomeres and telomerase activity accompany immortalization of Epstein\u2013Barr virus-transformed human B lymphocytes. J Virol 68: 3410\u20133414.","journal-title":"J Virol"},{"key":"BFonc2009359_CR8","doi-asserted-by":"publisher","first-page":"2100","DOI":"10.1101\/gad.1346005","volume":"19","author":"T de Lange","year":"2005","unstructured":"de Lange T . (2005). Shelterin: the protein complex that shapes and safeguards human telomeres. Genes Dev 19: 2100\u20132110.","journal-title":"Genes Dev"},{"key":"BFonc2009359_CR9","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1002\/cyto.a.20699","volume":"75","author":"WH De Vos","year":"2009","unstructured":"De Vos WH, Hoebe RA, Joss GH, Haffmans W, Baatout S, Van Oostveldt P et al. (2009). Controlled light exposure microscopy reveals dynamic telomere microterritories throughout the cell cycle. Cytometry A 75: 428\u2013439.","journal-title":"Cytometry A"},{"key":"BFonc2009359_CR10","first-page":"289","volume":"20","author":"V Diehl","year":"1977","unstructured":"Diehl V, Krause P, Hellriegel KP, Busche M, Schedel I, Laskewitz E . (1977). Lymphoid cell lines: in vitro cell markers in correlation to tumorigenicity in nude mice. Haematol Blood Transfus 20: 289\u2013296.","journal-title":"Haematol Blood Transfus"},{"key":"BFonc2009359_CR11","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1002\/jcp.10263","volume":"196","author":"R Dolcetti","year":"2003","unstructured":"Dolcetti R, Masucci MG . (2003). Epstein\u2013Barr virus: induction and control of cell transformation. J Cell Physiol 196: 207\u2013218.","journal-title":"J Cell Physiol"},{"key":"BFonc2009359_CR12","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s11010-008-9984-1","volume":"324","author":"B Gargouri","year":"2009","unstructured":"Gargouri B, Van Pelt J, El Feki Ael F, Attia H, Lassoued S . (2009). Induction of Epstein\u2013Barr virus (EBV) lytic cycle in vitro causes oxidative stress in lymphoblastoid B cell lines. Mol Cell Biochem 324: 55\u201363.","journal-title":"Mol Cell Biochem"},{"key":"BFonc2009359_CR13","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1084\/jem.182.5.1265","volume":"182","author":"P Garrone","year":"1995","unstructured":"Garrone P, Neidhardt EM, Garcia E, Galibert L, van Kooten C, Banchereau J . (1995). Fas ligation induces apoptosis of CD40-activated human B lymphocytes. J Exp Med 182: 1265\u20131273.","journal-title":"J Exp Med"},{"key":"BFonc2009359_CR14","first-page":"591","volume":"58","author":"J Gordon","year":"1986","unstructured":"Gordon J, Walker L, Guy G, Brown G, Rowe M, Rickinson A . (1986). Control of human B-lymphocyte replication. II. Transforming Epstein\u2013Barr virus exploits three distinct viral signals to undermine three separate control points in B-cell growth. Immunology 58: 591\u2013595.","journal-title":"Immunology"},{"key":"BFonc2009359_CR15","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.1073\/pnas.0810619106","volume":"106","author":"B Gruhne","year":"2009","unstructured":"Gruhne B, Sompallae R, Marescotti D, Kamranvar SA, Gastaldello S, Masucci MG . (2009). The Epstein\u2013Barr virus nuclear antigen-1 promotes genomic instability via induction of reactive oxygen species. Proc Natl Acad Sci USA 106: 2313\u20132318.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc2009359_CR16","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1038\/2281053a0","volume":"228","author":"P Gunven","year":"1970","unstructured":"Gunven P, Klein G, Henle G, Henle W, Clifford P . (1970). Epstein\u2013Barr virus in Burkitt's lymphoma and nasopharyngeal carcinoma. Antibodies to EBV associated membrane and viral capsid antigens in Burkitt lymphoma patients. Nature 228: 1053\u20131056.","journal-title":"Nature"},{"key":"BFonc2009359_CR17","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1073\/pnas.59.1.94","volume":"59","author":"G Henle","year":"1968","unstructured":"Henle G, Henle W, Diehl V . (1968). Relation of Burkitt's tumor-associated herpes-type virus to infectious mononucleosis. Proc Natl Acad Sci USA 59: 94\u2013101.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc2009359_CR18","first-page":"79","volume":"36","author":"W Henle","year":"1973","unstructured":"Henle W, Henle G . (1973a). Epstein\u2013Barr virus-related serology in Hodgkin's disease. Natl Cancer Inst Monogr 36: 79\u201384.","journal-title":"Natl Cancer Inst Monogr"},{"key":"BFonc2009359_CR19","first-page":"1419","volume":"33","author":"W Henle","year":"1973","unstructured":"Henle W, Henle G . (1973b). Evidence for an oncogenic potential of the Epstein\u2013Barr virus. Cancer Res 33: 1419\u20131423.","journal-title":"Cancer Res"},{"key":"BFonc2009359_CR20","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/978-3-642-67236-1_4","volume-title":"The Epstein\u2013Barr Virus","author":"W Henle","year":"1979","unstructured":"Henle W, Henle G . (1979). Seroepidemiology of the virus. In: Epstein MA, Achong BG (eds). The Epstein\u2013Barr Virus. Springer-Verlag: Berlin, Germany. pp 61\u201378."},{"key":"BFonc2009359_CR21","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1128\/jb.92.1.269-271.1966","volume":"92","author":"W Henle","year":"1966","unstructured":"Henle W, Hummeler K, Henle G . (1966). Antibody coating and agglutination of virus particles separated from the EB3 line of Burkitt lymphoma cells. J Bacteriol 92: 269\u2013271.","journal-title":"J Bacteriol"},{"key":"BFonc2009359_CR22","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1097\/00007890-200207270-00009","volume":"74","author":"PA Hopwood","year":"2002","unstructured":"Hopwood PA, Brooks L, Parratt R, Hunt BJ, Bokhari M, Thomas JA et al. (2002). Persistent Epstein\u2013Barr virus infection: unrestricted latent and lytic viral gene expression in healthy immunosuppressed transplant recipients. Transplantation 74: 194\u2013202.","journal-title":"Transplantation"},{"key":"BFonc2009359_CR23","doi-asserted-by":"publisher","first-page":"3745","DOI":"10.1002\/(SICI)1521-4141(199911)29:11<3745::AID-IMMU3745>3.0.CO;2-1","volume":"29","author":"BT Hu","year":"1999","unstructured":"Hu BT, Insel RA . (1999). Up-regulation of telomerase in human B lymphocytes occurs independently of cellular proliferation and with expression of the telomerase catalytic subunit. Eur J Immunol 29: 3745\u20133753.","journal-title":"Eur J Immunol"},{"key":"BFonc2009359_CR24","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1182\/blood.V89.4.1299","volume":"89","author":"H Igarashi","year":"1997","unstructured":"Igarashi H, Sakaguchi N . (1997). Telomerase activity is induced in human peripheral B lymphocytes by the stimulation to antigen receptor. Blood 89: 1299\u20131307.","journal-title":"Blood"},{"key":"BFonc2009359_CR25","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.cancergencyto.2006.10.010","volume":"173","author":"JP Jeon","year":"2007","unstructured":"Jeon JP, Shim SM, Nam HY, Baik SY, Kim JW, Han BG . (2007). Copy number increase of 1p36.33 and mitochondrial genome amplification in Epstein\u2013Barr virus-transformed lymphoblastoid cell lines. Cancer Genet Cytogenet 173: 122\u2013130.","journal-title":"Cancer Genet Cytogenet"},{"key":"BFonc2009359_CR26","first-page":"33","volume":"110","author":"J Joncas","year":"1974","unstructured":"Joncas J, Boucher J, Granger-Julien M, Filion C . (1974). Epstein\u2013Barr virus infection in the neonatal period and in childhood. Can Med Assoc J 110: 33\u201337.","journal-title":"Can Med Assoc J"},{"key":"BFonc2009359_CR27","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1081\/IMM-100104023","volume":"30","author":"D Jung","year":"2001","unstructured":"Jung D, Neron S, Lemieux R, Roy A, Richard M . (2001). Telomere-independent reduction of human B lymphocyte: proliferation during long-term culture. Immunol Invest 30: 157\u2013168.","journal-title":"Immunol Invest"},{"key":"BFonc2009359_CR28","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1007\/s10495-006-8048-9","volume":"11","author":"AF Kabore","year":"2006","unstructured":"Kabore AF, Sun J, Hu X, McCrea K, Johnston JB, Gibson SB . (2006). The TRAIL apoptotic pathway mediates proteasome inhibitor induced apoptosis in primary chronic lymphocytic leukemia cells. Apoptosis 11: 1175\u20131193.","journal-title":"Apoptosis"},{"key":"BFonc2009359_CR29","doi-asserted-by":"publisher","first-page":"5115","DOI":"10.1038\/sj.onc.1210324","volume":"26","author":"SA Kamranvar","year":"2007","unstructured":"Kamranvar SA, Gruhne B, Szeles A, Masucci MG . (2007). Epstein\u2013Barr virus promotes genomic instability in Burkitt's lymphoma. Oncogene 26: 5115\u20135123.","journal-title":"Oncogene"},{"key":"BFonc2009359_CR30","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1046\/j.1432-0436.1998.6240203.x","volume":"62","author":"H Kataoka","year":"1997","unstructured":"Kataoka H, Tahara H, Watanabe T, Sugawara M, Ide T, Goto M et al. (1997). Immortalization of immunologically committed Epstein\u2013Barr virus-transformed human B-lymphoblastoid cell lines accompanied by a strong telomerase activity. Differentiation 62: 203\u2013211.","journal-title":"Differentiation"},{"key":"BFonc2009359_CR31","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1159\/000078201","volume":"105","author":"SH Kim","year":"2004","unstructured":"Kim SH, McQueen PG, Lichtman MK, Shevach EM, Parada LA, Misteli T . (2004). Spatial genome organization during T-cell differentiation. Cytogenet Genome Res 105: 292\u2013301.","journal-title":"Cytogenet Genome Res"},{"key":"BFonc2009359_CR32","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1038\/leu.2008.314","volume":"23","author":"H Knecht","year":"2009","unstructured":"Knecht H, Sawan B, Lichtensztejn D, Lemieux B, Wellinger RJ, Mai S . (2009). The 3D nuclear organization of telomeres marks the transition from Hodgkin to Reed\u2013Sternberg cells. Leukemia 23: 565\u2013573.","journal-title":"Leukemia"},{"key":"BFonc2009359_CR33","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1101\/gad.1634008","volume":"22","author":"A Konishi","year":"2008","unstructured":"Konishi A, de Lange T . (2008). Cell cycle control of telomere protection and NHEJ revealed by a ts mutation in the DNA-binding domain of TRF2. Genes Dev 22: 1221\u20131230.","journal-title":"Genes Dev"},{"key":"BFonc2009359_CR34","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/s11010-008-9755-z","volume":"313","author":"S Lassoued","year":"2008","unstructured":"Lassoued S, Ben Ameur R, Ayadi W, Gargouri B, Ben Mansour R, Attia H . (2008). Epstein\u2013Barr virus induces an oxidative stress during the early stages of infection in B lymphocytes, epithelial, and lymphoblastoid cell lines. Mol Cell Biochem 313: 179\u2013186.","journal-title":"Mol Cell Biochem"},{"key":"BFonc2009359_CR35","doi-asserted-by":"publisher","first-page":"9613","DOI":"10.1073\/pnas.0407512102","volume":"102","author":"SF Louis","year":"2005","unstructured":"Louis SF, Vermolen BJ, Garini Y, Young IT, Guffei A, Lichtensztejn Z et al. (2005). c-Myc induces chromosomal rearrangements through telomere and chromosome remodeling in the interphase nucleus. Proc Natl Acad Sci USA 102: 9613\u20139618.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc2009359_CR36","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1093\/oso\/9780199638833.003.0004","volume-title":"FISH: A Practical Approach","author":"S Mai","year":"2002","unstructured":"Mai S, Wiener F . (2002). Murine FISH. In: Beatty B, Mai S, Squire J (eds). FISH: A Practical Approach. Oxford University Press: Oxford. pp 55\u201367."},{"key":"BFonc2009359_CR37","doi-asserted-by":"publisher","first-page":"2139","DOI":"10.1007\/s00705-005-0557-2","volume":"150","author":"A Mochida","year":"2005","unstructured":"Mochida A, Gotoh E, Senpuku H, Harada S, Kitamura R, Takahashi T et al. (2005). Telomere size and telomerase activity in Epstein\u2013Barr virus (EBV)-positive and EBV-negative Burkitt's lymphoma cell lines. Arch Virol 150: 2139\u20132150.","journal-title":"Arch Virol"},{"key":"BFonc2009359_CR38","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1242\/jcs.114.2.377","volume":"114","author":"RG Nagele","year":"2001","unstructured":"Nagele RG, Velasco AQ, Anderson WJ, McMahon DJ, Thomson Z, Fazekas J et al. (2001). Telomere associations in interphase nuclei: possible role in maintenance of interphase chromosome topology. J Cell Sci 114: 377\u2013388.","journal-title":"J Cell Sci"},{"key":"BFonc2009359_CR39","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1001\/jama.1968.03140030037009","volume":"203","author":"JC Niederman","year":"1968","unstructured":"Niederman JC, McCollum RW, Henle G, Henle W . (1968). Infectious mononucleosis. Clinical manifestations in relation to EB virus antibodies. JAMA 203: 205\u2013209.","journal-title":"JAMA"},{"key":"BFonc2009359_CR40","first-page":"25","volume":"5","author":"K Nilsson","year":"1992","unstructured":"Nilsson K . (1992). Human B-lymphoid cell lines. Hum Cell 5: 25\u201341.","journal-title":"Hum Cell"},{"key":"BFonc2009359_CR41","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1002\/ijc.2910190309","volume":"19","author":"K Nilsson","year":"1977","unstructured":"Nilsson K, Giovanella BC, Stehlin JS, Klein G . (1977). Tumorigenicity of human hematopoietic cell lines in athymic nude mice. Int J Cancer 19: 337\u2013344.","journal-title":"Int J Cancer"},{"key":"BFonc2009359_CR42","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1002\/ijc.2910150217","volume":"15","author":"K Nilsson","year":"1975","unstructured":"Nilsson K, Ponten J . (1975). Classification and biological nature of established human hematopoietic cell lines. Int J Cancer 15: 321\u2013341.","journal-title":"Int J Cancer"},{"key":"BFonc2009359_CR43","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1099\/vir.0.19704-0","volume":"85","author":"J O\u2019Nions","year":"2004","unstructured":"O\u2019Nions J, Allday MJ . (2004). Proliferation and differentiation in isogenic populations of peripheral B cells activated by Epstein\u2013Barr virus or T cell-derived mitogens. J Gen Virol 85: 881\u2013895.","journal-title":"J Gen Virol"},{"key":"BFonc2009359_CR44","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1093\/hmg\/6.6.905","volume":"6","author":"K Oexle","year":"1997","unstructured":"Oexle K, Zwirner A . (1997). Advanced telomere shortening in respiratory chain disorders. Hum Mol Genet 6: 905\u2013908.","journal-title":"Hum Mol Genet"},{"key":"BFonc2009359_CR45","first-page":"517","volume":"137","author":"M Okano","year":"1990","unstructured":"Okano M, Taguchi Y, Nakamine H, Pirruccello SJ, Davis JR, Beisel KW et al. (1990). Characterization of Epstein\u2013Barr virus-induced lymphoproliferation derived from human peripheral blood mononuclear cells transferred to severe combined immunodeficient mice. Am J Pathol 137: 517\u2013522.","journal-title":"Am J Pathol"},{"key":"BFonc2009359_CR46","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/S0165-4608(01)00420-4","volume":"129","author":"M Okubo","year":"2001","unstructured":"Okubo M, Tsurukubo Y, Higaki T, Kawabe T, Goto M, Murase T et al. (2001). Clonal chromosomal aberrations accompanied by strong telomerase activity in immortalization of human B-lymphoblastoid cell lines transformed by Epstein\u2013Barr virus. Cancer Genet Cytogenet 129: 30\u201334.","journal-title":"Cancer Genet Cytogenet"},{"key":"BFonc2009359_CR47","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/0140-6736(91)90943-J","volume":"337","author":"G Pallesen","year":"1991","unstructured":"Pallesen G, Hamilton-Dutoit SJ, Rowe M, Young LS . (1991). Expression of Epstein\u2013Barr virus latent gene products in tumour cells of Hodgkin's disease. Lancet 337: 320\u2013322.","journal-title":"Lancet"},{"key":"BFonc2009359_CR48","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/S0140-6736(80)90792-8","volume":"1","author":"DT Purtilo","year":"1980","unstructured":"Purtilo DT . (1980). Epstein\u2013Barr-virus-induced oncogenesis in immune-deficient individuals. Lancet 1: 300\u2013303.","journal-title":"Lancet"},{"key":"BFonc2009359_CR49","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1128\/jvi.61.5.1310-1317.1987","volume":"61","author":"AB Rickinson","year":"1987","unstructured":"Rickinson AB, Young LS, Rowe M . (1987). Influence of the Epstein\u2013Barr virus nuclear antigen EBNA 2 on the growth phenotype of virus-transformed B cells. J Virol 61: 1310\u20131317.","journal-title":"J Virol"},{"key":"BFonc2009359_CR50","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1111\/j.1365-2141.1986.tb02952.x","volume":"62","author":"CM Rooney","year":"1986","unstructured":"Rooney CM, Wimperis JZ, Brenner MK, Patterson J, Hoffbrand AV, Prentice HG . (1986). Natural killer cell activity following T-cell depleted allogeneic bone marrow transplantation. Br J Haematol 62: 413\u2013420.","journal-title":"Br J Haematol"},{"key":"BFonc2009359_CR51","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1038\/267052a0","volume":"267","author":"A Rosen","year":"1977","unstructured":"Rosen A, Gergely P, Jondal M, Klein G, Britton S . (1977). Polyclonal Ig production after Epstein\u2013Barr virus infection of human lymphocytes in vitro. Nature 267: 52\u201354.","journal-title":"Nature"},{"key":"BFonc2009359_CR52","doi-asserted-by":"publisher","first-page":"2599","DOI":"10.1002\/j.1460-2075.1986.tb04540.x","volume":"5","author":"DT Rowe","year":"1986","unstructured":"Rowe DT, Rowe M, Evan GI, Wallace LE, Farrell PJ, Rickinson AB . (1986). Restricted expression of EBV latent genes and T-lymphocyte-detected membrane antigen in Burkitt's lymphoma cells. EMBO J 5: 2599\u20132607.","journal-title":"EMBO J"},{"key":"BFonc2009359_CR53","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1128\/jvi.66.1.122-131.1992","volume":"66","author":"M Rowe","year":"1992","unstructured":"Rowe M, Lear AL, Croom-Carter D, Davies AH, Rickinson AB . (1992). Three pathways of Epstein\u2013Barr virus gene activation from EBNA1-positive latency in B lymphocytes. J Virol 66: 122\u2013131.","journal-title":"J Virol"},{"key":"BFonc2009359_CR54","doi-asserted-by":"publisher","first-page":"2743","DOI":"10.1002\/j.1460-2075.1987.tb02568.x","volume":"6","author":"M Rowe","year":"1987","unstructured":"Rowe M, Rowe DT, Gregory CD, Young LS, Farrell PJ, Rupani H et al. (1987). Differences in B cell growth phenotype reflect novel patterns of Epstein\u2013Barr virus latent gene expression in Burkitt's lymphoma cells. EMBO J 6: 2743\u20132751.","journal-title":"EMBO J"},{"key":"BFonc2009359_CR55","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1128\/jvi.63.3.1031-1039.1989","volume":"63","author":"M Rowe","year":"1989","unstructured":"Rowe M, Young LS, Cadwallader K, Petti L, Kieff E, Rickinson AB . (1989). Distinction between Epstein\u2013Barr virus type A (EBNA 2A) and type B (EBNA 2B) isolates extends to the EBNA 3 family of nuclear proteins. J Virol 63: 1031\u20131039.","journal-title":"J Virol"},{"key":"BFonc2009359_CR56","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1084\/jem.173.1.147","volume":"173","author":"M Rowe","year":"1991","unstructured":"Rowe M, Young LS, Crocker J, Stokes H, Henderson S, Rickinson AB . (1991). Epstein\u2013Barr virus (EBV)-associated lymphoproliferative disease in the SCID mouse model: implications for the pathogenesis of EBV-positive lymphomas in man. J Exp Med 173: 147\u2013158.","journal-title":"J Exp Med"},{"key":"BFonc2009359_CR57","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1038\/270729a0","volume":"270","author":"CM Steel","year":"1977","unstructured":"Steel CM, Philipson J, Arthur E, Gardiner SE, Newton MS, McIntosh RV . (1977). Possibility of EB virus preferentially transforming a subpopulation of human B lymphocytes. Nature 270: 729\u2013731.","journal-title":"Nature"},{"key":"BFonc2009359_CR58","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/S0047-6374(98)00131-6","volume":"107","author":"M Sugimoto","year":"1999","unstructured":"Sugimoto M, Ide T, Goto M, Furuichi Y . (1999). Reconsideration of senescence, immortalization and telomere maintenance of Epstein\u2013Barr virus-transformed human B-lymphoblastoid cell lines. Mech Ageing Dev 107: 51\u201360.","journal-title":"Mech Ageing Dev"},{"key":"BFonc2009359_CR59","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1038\/sj.onc.1201377","volume":"15","author":"H Tahara","year":"1997","unstructured":"Tahara H, Tokutake Y, Maeda S, Kataoka H, Watanabe T, Satoh M et al. (1997). Abnormal telomere dynamics of B-lymphoblastoid cell strains from Werner's syndrome patients transformed by Epstein\u2013Barr virus. Oncogene 15: 1911\u20131920.","journal-title":"Oncogene"},{"key":"BFonc2009359_CR60","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1089\/104454903770946700","volume":"22","author":"T Takahashi","year":"2003","unstructured":"Takahashi T, Kawabe T, Okazaki Y, Itoh C, Noda K, Tajima M et al. (2003). in vitro establishment of tumorigenic human B-lymphoblastoid cell lines transformed by Epstein\u2013Barr virus. DNA Cell Biol 22: 727\u2013735.","journal-title":"DNA Cell Biol"},{"key":"BFonc2009359_CR61","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1016\/S0140-6736(89)92469-0","volume":"1","author":"JA Thomas","year":"1989","unstructured":"Thomas JA, Crawford DH . (1989). Epstein\u2013Barr virus associated B-cell lymphomas in AIDS and after organ transplantation. Lancet 1: 1075\u20131076.","journal-title":"Lancet"},{"key":"BFonc2009359_CR62","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1097\/00007890-199005000-00022","volume":"49","author":"JA Thomas","year":"1990","unstructured":"Thomas JA, Hotchin NA, Allday MJ, Amlot P, Rose M, Yacoub M et al. (1990). Immunohistology of Epstein\u2013Barr virus-associated antigens in B cell disorders from immunocompromised individuals. Transplantation 49: 944\u2013953.","journal-title":"Transplantation"},{"key":"BFonc2009359_CR63","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/35095584","volume":"1","author":"DA Thorley-Lawson","year":"2001","unstructured":"Thorley-Lawson DA . (2001). Epstein\u2013Barr virus: exploiting the immune system. Nat Rev Immunol 1: 75\u201382.","journal-title":"Nat Rev Immunol"},{"key":"BFonc2009359_CR64","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1056\/NEJMra032015","volume":"350","author":"DA Thorley-Lawson","year":"2004","unstructured":"Thorley-Lawson DA, Gross A . (2004). Persistence of the Epstein\u2013Barr virus and the origins of associated lymphomas. N Engl J Med 350: 1328\u20131337.","journal-title":"N Engl J Med"},{"key":"BFonc2009359_CR65","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/S0092-8674(00)80932-0","volume":"92","author":"B van Steensel","year":"1998","unstructured":"van Steensel B, Smogorzewska A, de Lange T . (1998). TRF2 protects human telomeres from end-to-end fusions. Cell 92: 401\u2013413.","journal-title":"Cell"},{"key":"BFonc2009359_CR66","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/j.molcel.2005.09.024","volume":"20","author":"RE Verdun","year":"2005","unstructured":"Verdun RE, Crabbe L, Haggblom C, Karlseder J . (2005). Functional human telomeres are recognized as DNA damage in G2 of the cell cycle. Mol Cell 20: 551\u2013561.","journal-title":"Mol Cell"},{"key":"BFonc2009359_CR67","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/j.cell.2006.09.034","volume":"127","author":"RE Verdun","year":"2006","unstructured":"Verdun RE, Karlseder J . (2006). The DNA damage machinery and homologous recombination pathway act consecutively to protect human telomeres. Cell 127: 709\u2013720.","journal-title":"Cell"},{"key":"BFonc2009359_CR68","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1002\/cyto.a.20159","volume":"67","author":"BJ Vermolen","year":"2005","unstructured":"Vermolen BJ, Garini Y, Mai S, Mougey V, Fest T, Chuang TC et al. (2005). Characterizing the three-dimensional organization of telomeres. Cytometry A 67: 144\u2013150.","journal-title":"Cytometry A"},{"key":"BFonc2009359_CR69","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1002\/ijc.2910500217","volume":"50","author":"J Walter","year":"1992","unstructured":"Walter J, Moller P, Moldenhauer G, Schirrmacher V, Pawlita M, Wolf J . (1992). Local growth of a Burkitt's lymphoma versus disseminated invasive growth of the autologous EBV-immortalized lymphoblastoid cells and their somatic cell hybrids in SCID mice. Int J Cancer 50: 265\u2013273.","journal-title":"Int J Cancer"},{"key":"BFonc2009359_CR70","doi-asserted-by":"publisher","first-page":"3452","DOI":"10.1073\/pnas.84.10.3452","volume":"84","author":"F Wang","year":"1987","unstructured":"Wang F, Gregory CD, Rowe M, Rickinson AB, Wang D, Birkenbach M et al. (1987). Epstein\u2013Barr virus nuclear antigen 2 specifically induces expression of the B-cell activation antigen CD23. Proc Natl Acad Sci USA 84: 3452\u20133456.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc2009359_CR71","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1023\/A:1025016828544","volume":"11","author":"C Weierich","year":"2003","unstructured":"Weierich C, Brero A, Stein S, von Hase J, Cremer C, Cremer T et al. (2003). Three-dimensional arrangements of centromeres and telomeres in nuclei of human and murine lymphocytes. Chromosome Res 11: 485\u2013502.","journal-title":"Chromosome Res"},{"key":"BFonc2009359_CR72","doi-asserted-by":"publisher","first-page":"10827","DOI":"10.1073\/pnas.94.20.10827","volume":"94","author":"NP Weng","year":"1997","unstructured":"Weng NP, Granger L, Hodes RJ . (1997). Telomere lengthening and telomerase activation during human B cell differentiation. Proc Natl Acad Sci USA 94: 10827\u201310832.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc2009359_CR73","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1016\/0140-6736(91)93322-Z","volume":"337","author":"LS Young","year":"1991","unstructured":"Young LS, Deacon EM, Rowe M, Crocker J, Herbst H, Niedobitek G et al. (1991). Epstein\u2013Barr virus latent genes in tumour cells of Hodgkin's disease. Lancet 337: 1617.","journal-title":"Lancet"},{"key":"BFonc2009359_CR74","doi-asserted-by":"publisher","first-page":"5108","DOI":"10.1038\/sj.onc.1206556","volume":"22","author":"LS Young","year":"2003","unstructured":"Young LS, Murray PG . (2003). Epstein\u2013Barr virus and oncogenesis: from latent genes to tumours. Oncogene 22: 5108\u20135121.","journal-title":"Oncogene"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/onc2009359.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/onc2009359","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/onc2009359.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T01:24:37Z","timestamp":1739409877000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/onc2009359"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,11,2]]},"references-count":74,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,1,28]]}},"alternative-id":["BFonc2009359"],"URL":"https:\/\/doi.org\/10.1038\/onc.2009.359","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,11,2]]},"assertion":[{"value":"11 March 2009","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2009","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2009","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 November 2009","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}